Pulmonary hypertension patients get continued access to study drugs in new safety trial
Disease control
Recruiting now
This study is for people with pulmonary hypertension (high blood pressure in the lungs) who were already taking an experimental drug in a previous clinical trial. It lets them keep receiving the drug after the earlier study ends, while doctors monitor long-term safety. About 280 …
Phase: PHASE3 • Sponsor: Actelion • Aim: Disease control
Last updated May 17, 2026 07:03 UTC